epigallocatechin gallate has been researched along with Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
| Frias, I; Granja, A; Neves, AR; Pinheiro, M; Reis, S | 1 |
| Chakraborti, S; Chakraborti, T; Chowdhury, A; Pramanik, PK; Sarkar, J | 1 |
3 review(s) available for epigallocatechin gallate and Disease
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems.
Topics: Animals; Catechin; Disease; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles | 2017 |
Protective role of epigallocatechin-3-gallate in health and disease: A perspective.
Topics: Animals; Catechin; Disease; Health; Humans; Models, Biological; Protective Agents | 2016 |